Medullary thyroid cancer is a rare cancer diagnosed in about 1,200 patients annually in the U.S. Because it’s often a silent disease, many patients are diagnosed at an advanced stage.
Recently, there has been tremendous progress made in treating this disease with targeted therapy. We recently spoke with Mimi Hu, M.D., to learn more. She shared some challenges in treating this disease and advances that have been made just this year...
I have suffered from migraines for 30 years. And to cope with the pain, I enjoy journaling. It helps me to distract myself and find clarity...
Studying new cancer therapies through clinical trials is essential for progress in cancer care. Phase I clinical trials are designed to evaluate...
Now that we’re several months into the COVID-19 pandemic, many of us are feeling the emotional toll of the uncertainty, worry and dramatic changes to our habits and our lives.
“While it’s normal to have frequent thoughts of COVID-19, be mindful if these thoughts become more frequent, or start to impact your daily life,” says Catherine Powers-James, Ph.D., a clinical psychologist in our Integrative Medicine Center.
Here,...
When I learned six years ago that I carry a genetic mutation called CDH1, my initial response was anger. I had just gotten married, and my...
Since childhood, Birdia Churchwell has been fascinated by science.
“I was interested in the why, so I spent my time reading, asking...
When I was diagnosed with breast cancer at MD Anderson in January 2019, my biggest concern wasn’t actually my breasts. It was my heart. Because...
In cancer, there are often large-scale deletions, rearrangements or other disruptions to our genetic information, which lead to a phenomenon...
Your body is home to trillions of microbes. These bacteria, viruses, fungi and other organisms impact everything from how you process food...
I’ve been coming to MD Anderson for almost 11 years now, because I have a rare genetic condition called Li-Fraumeni Syndrome. It puts me at...